“It made me more confident that I have it under control”: Patient and provider perspectives on moving to a two-drug ART regimen in the United States and Spain

BACKGROUND: Two-drug regimens (2DR) to treat HIV infection have the potential to reduce long-term toxicity and increase therapeutic options for people living with HIV (PLHIV). Prior phase III trials, SWORD-1 and SWORD-2, as well as GEMINI-1 and GEMINI-2, have demonstrated that a dolutegravir-based 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Davis, Wendy, Mantsios, Andrea, Karver, Tahilin, Murray, Miranda, Punekar, Yogesh, Ward, Douglas, Bredeek, U. Fritz, Moreno, Santiago, Merino, Dolores, Knobel, Hernando, Campis, Antonio, Kerrigan, Deanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194407/
https://www.ncbi.nlm.nih.gov/pubmed/32357195
http://dx.doi.org/10.1371/journal.pone.0232473

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194407/
https://www.ncbi.nlm.nih.gov/pubmed/32357195
http://dx.doi.org/10.1371/journal.pone.0232473

Ejemplares similares